造血-话题@MedSci

#造血#

356篇内容 | 2774人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1494694, encodeId=ea4014946949c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演, objectType=article, longId=180547, objectId=68dd18054e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68dd18054e3c, replyNumber=0, likeNumber=54, createdTime=2019-10-07, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68dd18054e3c, moduleTitle=上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68dd18054e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494693, encodeId=61e1149469312, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：GSK3抑制剂负载纳米颗粒的供体细胞可增强宫内造血细胞移植的效果, objectType=article, longId=180491, objectId=deca180491e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deca180491e1, replyNumber=0, likeNumber=58, createdTime=2019-10-05, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deca180491e1, moduleTitle=Blood：GSK3抑制剂负载纳米颗粒的供体细胞可增强宫内造血细胞移植的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deca180491e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494692, encodeId=adcd1494692f1, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点, objectType=article, longId=179590, objectId=f88b1e959038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88b1e959038, replyNumber=0, likeNumber=69, createdTime=2019-09-18, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88b1e959038, moduleTitle=Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f88b1e959038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494691, encodeId=efa014946915c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, objectType=article, longId=178530, objectId=2cdd1e853070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdd1e853070, replyNumber=0, likeNumber=49, createdTime=2019-09-03, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdd1e853070, moduleTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdd1e853070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494690, encodeId=cfad149469033, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要, objectType=article, longId=178232, objectId=05f81e823285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05f81e823285, replyNumber=0, likeNumber=61, createdTime=2019-08-28, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05f81e823285, moduleTitle=Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05f81e823285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494689, encodeId=b1b51494689c1, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应, objectType=article, longId=178231, objectId=208f1e823181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=208f1e823181, replyNumber=0, likeNumber=74, createdTime=2019-08-28, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=208f1e823181, moduleTitle=Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=208f1e823181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494688, encodeId=de19149468855, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, objectType=article, longId=177725, objectId=7f3b1e772586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f3b1e772586, replyNumber=0, likeNumber=24, createdTime=2019-08-17, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f3b1e772586, moduleTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f3b1e772586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494687, encodeId=f495149468edb, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：CX3CR1+MNC依赖细菌信号调控造血祖细胞, objectType=article, longId=177314, objectId=1c6c1e731490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c6c1e731490, replyNumber=0, likeNumber=56, createdTime=2019-08-10, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c6c1e731490, moduleTitle=Blood：CX3CR1+MNC依赖细菌信号调控造血祖细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c6c1e731490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494686, encodeId=17d8149468666, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, objectType=article, longId=176793, objectId=62aa1e679336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62aa1e679336, replyNumber=0, likeNumber=58, createdTime=2019-08-05, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62aa1e679336, moduleTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62aa1e679336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494685, encodeId=c8ba1494685d1, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：骨髓生态位中非造血细胞成分与HSCs的相互作用, objectType=article, longId=176659, objectId=b2c51e665955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2c51e665955, replyNumber=0, likeNumber=64, createdTime=2019-08-03, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2c51e665955, moduleTitle=Blood：骨髓生态位中非造血细胞成分与HSCs的相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2c51e665955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494684, encodeId=7a481494684d4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：通过去乙酰化激活LMO2对造血作用和T-ALL病的发生都必不可少, objectType=article, longId=176658, objectId=d15d1e6658f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15d1e6658f0, replyNumber=0, likeNumber=111, createdTime=2019-08-03, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15d1e6658f0, moduleTitle=Blood：通过去乙酰化激活LMO2对造血作用和T-ALL病的发生都必不可少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d15d1e6658f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494683, encodeId=209214946835c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率, objectType=article, longId=175264, objectId=29bb1e5264d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29bb1e5264d5, replyNumber=0, likeNumber=118, createdTime=2019-07-13, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29bb1e5264d5, moduleTitle=JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29bb1e5264d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494682, encodeId=0139149468268, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题, objectType=article, longId=168030, objectId=fdca16803091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdca16803091, replyNumber=0, likeNumber=0, createdTime=2019-06-12, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdca16803091, moduleTitle=《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdca16803091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494681, encodeId=8007149468194, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, objectType=article, longId=167613, objectId=b87a16e61344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b87a16e61344, replyNumber=0, likeNumber=0, createdTime=2019-06-05, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b87a16e61344, moduleTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b87a16e61344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494680, encodeId=3fd414946802d, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：同时进行造血细胞和肾移植治疗血液恶性病伴肾衰竭终末期的患者, objectType=article, longId=167586, objectId=ba5916e5861a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba5916e5861a, replyNumber=0, likeNumber=78, createdTime=2019-06-04, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba5916e5861a, moduleTitle=Blood：同时进行造血细胞和肾移植治疗血液恶性病伴肾衰竭终末期的患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba5916e5861a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494679, encodeId=96a114946e9fb, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关, objectType=article, longId=167273, objectId=dd0016e27301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd0016e27301, replyNumber=0, likeNumber=79, createdTime=2019-06-01, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd0016e27301, moduleTitle=Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd0016e27301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494678, encodeId=0c9c14946e89c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, objectType=article, longId=166721, objectId=b315166e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b315166e2142, replyNumber=0, likeNumber=88, createdTime=2019-05-25, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b315166e2142, moduleTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b315166e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494677, encodeId=767114946e767, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=NCCN临床实践指南：造血生长因子（2019.V2）, objectType=article, longId=166362, objectId=ae6f16636230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6f16636230, replyNumber=0, likeNumber=26, createdTime=2019-05-20, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6f16636230, moduleTitle=NCCN临床实践指南：造血生长因子（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6f16636230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494676, encodeId=adf714946e690, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Blood：维生素K拮抗剂可影响骨髓微环境及造血, objectType=article, longId=164685, objectId=a9ed164685a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9ed164685a7, replyNumber=0, likeNumber=99, createdTime=2019-04-22, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9ed164685a7, moduleTitle=Blood：维生素K拮抗剂可影响骨髓微环境及造血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9ed164685a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494675, encodeId=686a14946e578, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率, objectType=article, longId=164478, objectId=d8c61644e8a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8c61644e8a3, replyNumber=0, likeNumber=75, createdTime=2019-04-19, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8c61644e8a3, moduleTitle=新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8c61644e8a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血

2020-05-29

俅侠 (审核中...)

前往app查看评论内容

#造血#

上海累计实现467例造血干细胞捐献公益话剧《髓愿》首演

2019-10-07

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：GSK3抑制剂负载纳米颗粒的供体细胞可增强宫内造血细胞移植的效果

2019-10-05

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点

2019-09-18

俅侠 (审核中...)

前往app查看评论内容

#造血#

Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定

2019-09-03

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：KDM4/JMJD2组蛋白去甲基化对造血干细胞的维持至关重要

2019-08-28

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：多种受体酪氨酸激酶信号介导急性血小板减少时的造血干细胞反应

2019-08-28

俅侠 (审核中...)

前往app查看评论内容

#造血#

Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定

2019-08-17

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：CX3CR1+MNC依赖细菌信号调控造血祖细胞

2019-08-10

俅侠 (审核中...)

前往app查看评论内容

#造血#

SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植

2019-08-05

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：骨髓生态位中非造血细胞成分与HSCs的相互作用

2019-08-03

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：通过去乙酰化激活LMO2对造血作用和T-ALL病的发生都必不可少

2019-08-03

俅侠 (审核中...)

前往app查看评论内容

#造血#

JAMA：疫苗可有效降低自体造血干细胞移植后带状疱疹发生率

2019-07-13

俅侠 (审核中...)

前往app查看评论内容

#造血#

《自然》：重大突破！普通胶水破解造血干细胞体外扩增的谜题

2019-06-12

俅侠 (审核中...)

前往app查看评论内容

#造血#

英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制

2019-06-05

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：同时进行造血细胞和肾移植治疗血液恶性病伴肾衰竭终末期的患者

2019-06-04

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关

2019-06-01

俅侠 (审核中...)

前往app查看评论内容

#造血#

Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法

2019-05-25

俅侠 (审核中...)

前往app查看评论内容

#造血#

NCCN临床实践指南：造血生长因子（2019.V2）

2019-05-20

俅侠 (审核中...)

前往app查看评论内容

#造血#

Blood：维生素K拮抗剂可影响骨髓微环境及造血

2019-04-22

俅侠 (审核中...)

前往app查看评论内容

#造血#

新一代造血干细胞动员剂释倍灵®开出中国首张处方，显著提升非霍奇金淋巴瘤患者移植成功率

2019-04-19

科室
- - 订阅+
  - 更多科室
工具
服务